Low doses of lithium aspartate did not successfully treat neurologic symptoms of long COVID, a randomized, double-blind, placebo-controlled trial showed. In a study of 52 people with long COVID ...

The precision and bias of three a priori methods and an empirical method for predicting lithium dosage requirements were studied. Data on serum lithium concentrations were collected from inpatient ...

At low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID.  ...

A trial found low doses of lithium aspartate ineffective for long COVID-related fatigue and brain fog. However, a supplemental study indicated higher doses might help.

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID ...

ATLANTA, October 16, 2024--Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s ...

Value of installed lithium in the average electric vehicle sold globally plummets by 89%.

Lithium Medication Information Discover comprehensive details about Lithium, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed ...

BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...